Ledger.Open graph →
SEC Form D · filed October 15, 2019

Stealth BioTherapeutics Corp

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Grand Cayman, Cayman Islands
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (21)

Gerald Chan · Newton, MADirectorFrancis Chen · Newton, MADirectorKevin Mclaughlin · Newton, MADirectorIrene Mccarthy · Newton, MAExec · DirectorLu Huang · Newton, MADirectorLou Lange · Newton, MADirectorEdward Owens · Newton, MADirectorDonald Hatcher · Southlake, TXDirectorRichard J. Leifels · Stamford, CTExec · DirectorQueenie Kuang · Vancouver, British Columbia, CanadaDirectorGarrett B. Gee · Meridian, IDDirectorDavid Eaton · Vancouver, British Columbia, CanadaDirectorKirk R. Ouimet · Meridian, IDDirectorHerrick Lau · Vancouver, British Columbia, CanadaDirectorMichael G. O'Hara · New York, NYExec · DirectorThomas D. Wagner · New York, NYDirectorAra D. Cohen · New York, NYDirectorJonathan Herzog · Encino, CADirectorJohn Pingel · San Francisco, CADirectorMichael Gorriaran · Washington, Washington, D.C.DirectorAdam Treiser · Washington, Washington, D.C.Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗